
Miguel Lopez de Rodas Gregorio/medicine.yale.edu
Jan 21, 2025, 06:22
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy
A recent paper by Miguel Lopez de Rodas, Associate Research Scientist in Pathology at Yale Cancer Center, was mentioned by Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, on X
Authors: Miguel Lopez de Rodas, Maria Villalba-Esparza, Miguel Sanmamed, Lieping Chen, David Rimm and Kurt Schalper.
“Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.
Biological properties and biomarker potential for ICI therapy.”
More posts featuring Hidehito Horinouchi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 13:29
Mar 29, 2025, 12:32
Mar 29, 2025, 12:06
Mar 29, 2025, 12:00
Mar 29, 2025, 11:58
Mar 29, 2025, 11:36
Mar 29, 2025, 11:26